S0833, Bortezomib, Thalidomide, Lenalidomide, Combination Chemotherapy, and Autologous Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple Myeloma
Condition(s):Multiple Myeloma; Plasma Cell MyelomaLast Updated:March 6, 2015Withdrawn